Home LiteratureArticle Details
PMID: 8985357 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

The Epstein-Barr virus EBNA-1 promoter Qp requires an initiator-like element.

Journal of virology ·Vol. 71 ·No. 1 ·1997-01-00 ·Pages 354-61

Nonkwelo C, Ruf IK, Sample J

Abstract

Expression of the Epstein-Barr virus (EBV) EBNA-1 protein within EBV-positive tumor cells and subpopulations of latently infected B lymphocytes in vivo is mediated by the promoter Qp. Previous studies have established that Qp is a TATA-less promoter whose activation requires only proximal regulatory elements and that it is negatively autoregulated through two EBNA-1 binding sites downstream of the transcription initiation sites. The objective of this study was to better define the properties of an essential positive regulatory element (QRE-2) adjacent to a major transcription start site of Qp and to evaluate the contributions of other potential regulatory elements proximal to the Qp start site. Using DNA affinity purification and UV cross-linking, we have identified the QRE-2-binding protein as a single polypeptide of approximately 40 kDa. The DNA-binding properties of this protein are clearly distinct from those of the TATA-binding protein, suggesting that in the absence of a TATA box, QRE-2 may function as an initiator element to direct assembly of TFIID near the transcription start site. Mutational analysis of potential regulatory elements, furthermore, indicated that the putative E2F binding sites within the EBNA-1 binding domain can exert a positive influence on Qp that is EBNA-1 independent, suggesting that these regulatory elements play an additional if not different role in Qp regulation than previously proposed. A model for the regulation of Qp consistent with the current and previous findings which provides for a simple but efficient mechanism of ensuring the EBNA-1 expression necessary to sustain long-term latency is presented.

MeSH Terms
Base Sequence DNA, Viral DNA-Binding Proteins/metabolism Epstein-Barr Virus Nuclear Antigens/genetics Herpesvirus 4, Human/genetics Humans Molecular Sequence Data Peptide Chain Initiation, Translational Promoter Regions, Genetic Regulatory Sequences, Nucleic Acid Transcription Factor TFIID Transcription Factors/metabolism
Chemicals
DNA, Viral DNA-Binding Proteins Epstein-Barr Virus Nuclear Antigens Transcription Factor TFIID Transcription Factors
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Nonkwelo C
Department of Virology and Molecular Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Ruf I K
Sample J
References (43)
43 references, click to expand
  1. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.
    Nucleic Acids Res. 1983 Mar 11;11(5):1475-89 PMID: 6828386
  2. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.
    J Exp Med. 1993 Feb 1;177(2):339-49 PMID: 8381153
  3. Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region.
    Cell. 1985 Oct;42(3):859-68 PMID: 2996781
  4. Epstein-Barr virus-positive Burkitt's lymphoma cells not recognized by virus-specific T-cell surveillance.
    Nature. 1985 Oct 17-23;317(6038):629-31 PMID: 2997615
  5. Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site.
    Proc Natl Acad Sci U S A. 1986 Jul;83(14):5096-100 PMID: 3460083
  6. Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas.
    J Virol. 1993 Oct;67(10):6303-8 PMID: 8396685
  7. An alternative pathway for transcription initiation involving TFII-I.
    Nature. 1993 Sep 23;365(6444):355-9 PMID: 8377828
  8. Constitutive binding of EBNA1 protein to the Epstein-Barr virus replication origin, oriP, with distortion of DNA structure during latent infection.
    EMBO J. 1993 Dec 15;12(13):4933-44 PMID: 8262037
  9. Role of flanking E box motifs in human immunodeficiency virus type 1 TATA element function.
    J Virol. 1994 Nov;68(11):7188-99 PMID: 7933101
  10. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.
    J Virol. 1994 Nov;68(11):7374-85 PMID: 7933121
  11. Reciprocal regulation of the Epstein-Barr virus BamHI-F promoter by EBNA-1 and an E2F transcription factor.
    Mol Cell Biol. 1994 Nov;14(11):7144-52 PMID: 7935429
  12. Characterization of the Epstein-Barr virus Fp promoter.
    Virology. 1995 Jan 10;206(1):183-95 PMID: 7831773
  13. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1.
    J Virol. 1995 Jun;69(6):3752-8 PMID: 7745723
  14. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.
    Nature. 1995 Jun 22;375(6533):685-8 PMID: 7540727
  15. Mechanism of active transcriptional repression by the retinoblastoma protein.
    Nature. 1995 Jun 29;375(6534):812-5 PMID: 7596417
  16. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells.
    Nature. 1985 Feb 28-Mar 6;313(6005):812-5 PMID: 2983224
  17. Affinity purification of sequence-specific DNA binding proteins.
    Proc Natl Acad Sci U S A. 1986 Aug;83(16):5889-93 PMID: 3461465
  18. Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells.
    EMBO J. 1986 Oct;5(10):2599-607 PMID: 3023050
  19. Human growth hormone as a reporter gene in regulation studies employing transient gene expression.
    Mol Cell Biol. 1986 Sep;6(9):3173-9 PMID: 3023965
  20. A promoter for the highly spliced EBNA family of RNAs of Epstein-Barr virus.
    J Virol. 1987 Nov;61(11):3424-30 PMID: 2822952
  21. Epstein-Barr virus gene expression in nasopharyngeal carcinoma.
    J Gen Virol. 1988 May;69 ( Pt 5):1051-65 PMID: 2836550
  22. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.
    Int J Cancer. 1988 Sep 15;42(3):329-38 PMID: 2843473
  23. Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes.
    Proc Natl Acad Sci U S A. 1990 Mar;87(5):1725-9 PMID: 2155423
  24. Transcription of the Epstein-Barr virus genome during latency in growth-transformed lymphocytes.
    J Virol. 1990 Apr;64(4):1667-74 PMID: 2157049
  25. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease.
    Lancet. 1991 Feb 9;337(8737):320-2 PMID: 1671232
  26. Differential expression of Epstein Barr viral transcripts for two proteins (TP1 and LMP) in lymphocyte and epithelial cells.
    Nucleic Acids Res. 1991 May 11;19(9):2435-40 PMID: 1710355
  27. The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein.
    Cell. 1991 Jun 14;65(6):1073-82 PMID: 1828394
  28. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site.
    Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6343-7 PMID: 1648738
  29. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
    Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6550-4 PMID: 1713681
  30. Transcription of the Epstein-Barr virus gene EBNA-1 from different promoters in nasopharyngeal carcinoma and B-lymphoblastoid cells.
    J Virol. 1992 Feb;66(2):706-14 PMID: 1370554
  31. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.
    J Exp Med. 1992 Jul 1;176(1):157-68 PMID: 1319456
  32. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
    J Exp Med. 1992 Jul 1;176(1):169-76 PMID: 1377222
  33. The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated.
    J Virol. 1992 Aug;66(8):4654-61 PMID: 1321268
  34. The Epstein-Barr virus BamHI F promoter is an early lytic promoter: lack of correlation with EBNA 1 gene transcription in group 1 Burkitt's lymphoma cell lines.
    J Virol. 1995 Aug;69(8):5039-47 PMID: 7609074
  35. Common themes in assembly and function of eukaryotic transcription complexes.
    Annu Rev Biochem. 1995;64:533-61 PMID: 7574492
  36. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines.
    Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10565-9 PMID: 7479841
  37. Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein.
    J Virol. 1996 Jan;70(1):623-7 PMID: 8523583
  38. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites.
    Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11544-8 PMID: 8524800
  39. Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance.
    Virology. 1995 Dec 20;214(2):633-7 PMID: 8553567
  40. Transcriptional repression and growth suppression by the p107 pocket protein.
    Mol Cell Biol. 1996 Jul;16(7):3606-14 PMID: 8668177
  41. Epstein-Barr virus and the B cell: that's all it takes.
    Trends Microbiol. 1996 May;4(5):204-8 PMID: 8727601
  42. Functional binding of the "TATA" box binding component of transcription factor TFIID to the -30 region of TATA-less promoters.
    Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):5814-8 PMID: 1321424
  43. Binding of TAFs to core elements directs promoter selectivity by RNA polymerase II.
    Cell. 1995 Jun 30;81(7):1115-25 PMID: 7600579
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1997-01-00
Pages
354-61
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC191058
Subset
IM
Grants
NCI NIH HHS · CA-21765 · United States
NCI NIH HHS · CA-56639 · United States
NIAID NIH HHS · T32-AI-07372 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]